Arkin Capital raises $100M to back a dozen early-stage biotechs
Arkin Capital raises $100M to back a dozen early-stage biotechs
Arkin Capital raises $100M to back a dozen early-stage biotechs
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page